You pay $299 a month for compounded semaglutide. Novo Nordisk charges $1,349 for Wegovy. But the raw ingredient — the actual semaglutide molecule — costs between $0.01 and $0.12 per dose. That's not a typo.
A March 2026 medRxiv study analyzed 33 shipments of semaglutide API (active pharmaceutical ingredient) traded between India, China, and the United States. The findings reveal a staggering disconnect between what the medication costs to produce and what patients actually pay.
The Real Numbers: What Semaglutide Costs to Make
According to the medRxiv analysis, the weighted average cost of semaglutide API was approximately $39,867 per kilogram. That sounds expensive — until you realize how little API goes into each dose.
A weekly 2.4mg maintenance dose of injectable semaglutide requires 0.0024 grams of API. At $39,867/kg, that works out to roughly $0.10 per dose. Even adding formulation, packaging, labor, transportation, a 27% tax, and a 30% profit margin, the production cost is still under $5 per monthly supply for injectable semaglutide.
The study also found that the disposable injection pens — not the drug itself — are the major cost driver. Each pen costs $0.30 to $2.50 to produce. Patients typically need 52 pens per year, making the device cost 8 to 68 times higher than the medication itself.
The Price Cascade: From Powder to Patient
| Stage | Estimated Cost | Notes |
|---|---|---|
| Raw API (1 month supply) | $0.40 – $0.48 | Based on 4 weekly doses at 2.4mg |
| Formulation & sterile compounding | $15 – $40 | 503B facility with cGMP compliance |
| Quality testing per batch | $2 – $5/patient | Potency and sterility testing, spread across batch |
| Pharmacy overhead | $40 – $80 | Rent, utilities, pharmacist salary, insurance |
| Cold-chain shipping | $10 – $25 | Express delivery with temperature control |
| Telehealth consultation | $20 – $50 | Prescriber evaluation (some platforms separate this) |
| Total production cost | $87 – $200 | What it actually costs to deliver to your door |
| Typical patient price (compounded) | $149 – $399 | 50–100% markup over production cost |
| Brand Wegovy (list price) | $1,349 | 27,000% markup over API cost |
Why Brand-Name Prices Are What They Are
It would be dishonest to say Novo Nordisk's pricing is purely profit-taking. Brand-name drug pricing factors in R&D costs (the STEP and SELECT trial programs cost billions), FDA regulatory approval process, ongoing pharmacovigilance and safety monitoring, global manufacturing at pharmaceutical-grade scale, legal defense budget (130+ lawsuits aren't free), and executive compensation and shareholder returns.
Novo Nordisk's R&D investment in semaglutide spans more than a decade, including the massive clinical trials that proved cardiovascular benefits. That data — which compounded products benefit from without paying for — is legitimately expensive to generate.
However, the gap between production cost and patient price remains jarring. Even if you're generous and attribute $200/month to R&D amortization, marketing, and profit — Wegovy at $1,349 still represents roughly $1,100/month of pure market pricing power.
The API Supply Chain
As of mid-2026, the semaglutide API market has shifted dramatically. Prices have fallen from roughly $900 per gram two years ago to $90–160 per gram for synthetic versions and approximately $50 per gram for recombinant variants. This price collapse has been driven by increased manufacturing capacity in India and China, Novo Nordisk's Indian patent expiry in March 2026, and at least 8 generic manufacturers now producing semaglutide in India.
For U.S. compounding pharmacies, the API still comes at a premium — pharmaceutical-grade material with certificates of analysis costs more than bulk research-grade powder. But the trend is clear: the raw ingredient is getting cheaper, not more expensive.
What About Tirzepatide?
Tirzepatide API data is harder to find publicly, but industry sources suggest it trades at a premium over semaglutide due to its more complex dual-agonist structure, fewer suppliers (Lilly's patent protection is stronger in most markets), and smaller production volumes. Still, the same basic math applies: the raw API is a tiny fraction of what patients pay.
Why This Matters for Your Decision
Understanding the cost structure helps you evaluate providers more critically. If a compounded semaglutide provider charges $99/month, they're operating on thin margins — which isn't inherently bad, but it means you should verify their quality testing and pharmacy sourcing. If a provider charges $400+/month for compounded semaglutide, you're paying for something beyond the medication itself (brand marketing, premium service, or simply higher margins).
The sweet spot for reputable compounded providers tends to be $149–$299/month — enough margin to support proper quality controls and licensed prescriber oversight, while still representing massive savings over brand-name options.
Our Take
The gap between what GLP-1 medications cost to produce and what patients pay is one of the most extreme in pharmaceutical history. Compounded providers dramatically reduce that gap but don't eliminate it. Brand-name pricing reflects real R&D investment but also significant market power. The most informed choice is one where you understand exactly what you're paying for — and what markup is reasonable for the quality assurance your health deserves.
GobyMeds
Semaglutide bundle from $99/mo, tirzepatide bundle from $133/mo. LegitScript-certified, 503A + 503B sourcing. Free consultation and free shipping. Use code x7X72r to save $25.
Paid link · Code x7X72r saves $25 · Compounded medications are not FDA-approved products.
Embody
Injectable compounded semaglutide from an FDA-registered 503B outsourcing facility. $149 first month, $299/mo ongoing. Includes prescriber consultation, medication, and shipping.
Paid link · Compounded medications are not FDA-approved products.
SkinnyRx
Three delivery formats — injectable, sublingual drops, and oral tablets — all from one provider. 503A compounding with LegitScript verification. Free physician consultation included.
Paid link · Compounded medications are not FDA-approved products.
Gala GLP-1
No price increases as your dose goes up — $179/mo at every dose tier. Compounded semaglutide with physician consultation, medication, and shipping included.
Lock In $179/mo →Paid link · Compounded medications are not FDA-approved products.